PriceSensitive

EnWave (TSXV:ENW) receives cannabis research license

Technology
TSXV:ENW
27 July 2020 11:45 (EDT)
EnWave - CEO, Brent Charleton.

Source: News Centre.

Technology company, EnWave (ENW) has been granted a cannabis research license from Health Canada.

The license is for the company’s facilities, which are based in Vancouver. EnWave will use the license to advance its in-house research into cannabis at those facilities.

The company’s proprietary Radiant Energy Vacuum (REV) drying technology has applications in the cannabis and hemp industry. Specifically, the technology can provide cannabis and hemp producers with a rapid post-harvest drying solution for their products. 

In addition to producing high-quality products, REV technology can also reduce processing bottlenecks at lower operating costs. It can also decrease the number of bacteria in the product, and reduce crop loss due to microbes and other quality issues.

As a result, several licensed cannabis and hemp producers have already adopted REV technology. The producers come from countries including Canada, the United States of America, Australia, New Zealand, and Switzerland. 

To capitalise on this growing market, EnWave has gained approval for independent research and development for cannabis products. The company can accelerate process development and data analytics for various cannabis properties, including terpenes and cannabinoid retention. 

Previous trials, which EnWave conducted at its licensed partners’ facilities yielded very positive results. With Health Canada’s research license in hand, the company can work independently at its own site, helping cannabis companies to upscale their drying operations. 

EnWave is currently conducting trials of various cannabis strains onsite, with hopes of attaining new licenses in the future. The company also plans to generate further REV equipment sales in the cannabis sector moving forward.

EnWave (ENW) is up 7.78 per cent and is trading at C$0.97 per share at 10:00am EDT.

Related News